Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
Joining in the world's fight against COVID-19 | LOG
You're good to go' – Taffix underlines its travel safe solution to combating viruses : The Moodie Davitt Report -The Moodie Davitt Report